A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the efficacy and safety of co-administrated
BR1018B and BR1018C in patients with essential hypertension and primary hypercholesterolemia